Lack of relationship between thalamic oscillations and attention in rats: Differential modulation by an alpha-2 antagonist

Brain Research Bulletin

Volumn 43, Issue 2, 1997, Pages 163-171

  Pauumala, Tarja ^c   Björklund, Markus ^c   Ruotsalainen, Sirja ^c   Riekkinen, Minna ^c   Jäkälä, Pekka ^c   Haapalinna, Antti ^a   Björk, Erkki ^b   Riekkinen Jr , Paavo ^c   Sirviö, Jouni ^c  

^a ORION CORPORATION   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NONE

Author keywords

Alpha 2 antagonist; Attention; Impulsivity; Thalamic oscillations

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN ELECTROPHYSIOLOGY; FREQUENCY MODULATION; FUNCTIONAL ASSESSMENT; IMPULSIVENESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; THALAMUS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ATTENTION; IMIDAZOLES; MALE; RATS; RATS, WISTAR; TASK PERFORMANCE AND ANALYSIS; THALAMUS;

EID: 0030848242     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00433-9     Document Type: Article

References (42)

1. Diagnostic and statistical manual of mental disorders. (DSM-IV). 4th ed. 1994;78-85 APA, Washington, DC.
2. Brown C. S., Cooke S. C. Attention deficit hyperactivity disorder. Clinical features and treatment options. CNS Drugs. 1:1994;95-106.
3. Buzsáki G., Bickford R. G., Ponomareff G., Thal L. J., Mandel R., Gage F. H. Nucleus basalis and thalamic control neocortical activity of freely moving rat. J. Neurosci. 8:1988;4007-4026.
4. Buzsáki G., Kennedy MB., Solt V. B., Ziegler M. Noradrenergic control of thalamic oscillation: the role of α -2 receptors. Eur. J. Neurosci. 3:1990;222-229.
5. Carli M., Robbins T. W., Evenden J. L., Everitt B. J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction time task in rats: Implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 9:1983;361-380.
6. Cole B. J., Robbins T. W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: New evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berlin). 91:1987;458-466.
7. Cole B. J., Robbins T. W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal. Behav. Brain Res. 33:1989;165-179.
8. Desch L. W. Neurochemical aspects of attention deficit hyperactivity disorder. Accardo P. J., Blondis T. A., Whitman B. Y. Attention deficit disorders and hyperactivity in children. 1991;57-89 Marcel Dekker Inc, New York.
9. Dickinson S. L., Gadie B., Tulloch I. F. Specific α2 -adrenoceptor antagonists induce behavioural activation in the rat. J. Psychopharmacol. 4:1990;90-99.
10. Frick P. J., Lahey B. B. The nature and characteristics of attention-deficit hyperactivity disorder. School Psychol. Rev. 20:1991;163-173.
11. Fuster J. M. The prefrontal cortex. Anatomy, physiology, and neurophysiology of the frontal lobe. 2nd ed. 1989;3-32 Raven Press, New York.
12. Hunt R. D., Minderaa R. B., Cohen D. J. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. J. Am. Acad. Child. Psychol. 24:1985;617-629.
13. Inoue M., Van Luijtelaar J. M., Vossen J. M. H., Coenen A. M. L. Visual evoked potentials during spontaneously occurring spike-wave discharges in rats. Electroencephalogr. Clin. Neurophysiol. 84:1992;172-179.
14. 2 subtype specific drugs. Eur. J. Pharmacol. 282:1995;39-55.
15. McCormick D. A. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci. 12:1989;215-221.
16. McCormick D. A. Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophysiol. 9:1992;212-223.
17. Mesulam M.-M. Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol. 28:1990;597-613.
18. Micheletti G., Warter J. M., Marescaux C., Depaulis A., Tranchant C., Rumbach L., Vergens M. Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal like seizures. Eur. J. Pharmacol. 135:1987;397-402.
19. Morrow J. D. Psychostimulant medication: The pharmacotherapy of attention deficit hyperactivity disorder. Accardo P. J., Blondis T. A., Whitman B. Y. Attention deficit disorders and hyperactivity in children. 1991;301-331 Marcel Dekker, Inc, New York.
20. Muir J. L., Everitt B. J., Robbins T. W. The cerebral cortex of the rat and visual attentional function: Dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb. Cortex. 6:1996;470-481.
21. Olpe H.-C., Steinmann M. W., Jones R. S. G. Locus coeruleus as a target for psychogeriatric agents. Ann. NY Acad. Sci. 444:1985;394-405.
22. Olshausen B. A., Anderson C. H., Van Essen D. C. A neurobiological model of visual attention and invariant pattern recognition based on dynamic routing of information. J. Neurosci. 13:1993;4700-4719.
23. Posner M. I., Dehaene S. Attentional networks. Trends Neurosci. 17:1994;75-79.
24. Puumala T., Ruotsalainen S., Jäkälä P., Koivisto E., Riekkinen P. Jr., Sirviö J. Behavioral and pharmacological studies on the validation of a new model for attention deficit hyperactivity disorder. Neurobiol. Learn. Mem. 66:1996;198-211.
25. Rakic P. Corticogenesis in human and nonhuman primates. Gazzaniga M. S. The cognitive neuroscience. 1995;127-145 MIT Press, Cambridge, MA.
26. alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. J. Pharmacol. Exp. Ther. 270:1994;946-957.
27. Riekkinen P. Jr., Sirviö J., Jäkälä P., Lammintausta R., Riekkinen P. Interaction between the α2 -noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles. Brain Res. Bull. 25:1990;147-149.
28. Riekkinen P. Jr., Sirviö J., Miettinen R., Riekkinen P. Interaction between raphe dorsalis and nucleus basalis magnocellularis in the regulation of high-voltage spindle activity in rat neocortex. Brain Res. 526:1990;31-36.
29. 2 -adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats. Eur. J. Pharmcol. 235:1993;317-320.
30. Riekkinen P. Jr., Sirviö J., Ekonsalo T., Sirviö J. The effects of α2 -adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. Eur. J. Pharmacol. 238:1993;263-272.
31. Robbins T. W., Jones G. H., Sahakian B. J. Central stimulants, transmitters and attentional disorder: A perspective from animal studies. Sagvolden T., Archer T. Attention deficit disorder: Clinical and basic research. 1989;199-222 Lawrence Erlbaum Associates, Hillsdale, NJ.
32. Ruotsalainen S., Haapalinna A., Riekkinen P. Jr., Sirviö J. Dexmedetomidine reduces response tendency, but not accuracy or rats in attention and working memory tasks. Pharmacol. Biochem. Behav. 56:1997;31-40.
33. Sagvolden T., Wultz B., Moser E. I., Moser M.-B., Møorkrid L. Results from a comparative neurophysiological research program indicate altered reinforcement mechanisms in children with ADD. Sagvolden T., Archer T. Attention deficit disorder: Clinical and basic research. 1989;261-286 Lawrence Erlbaum Associates, Hillsdale, NJ.
34. Schachar R. Childhood hyperactivity. J. Child Psychol. Psychiatry. 32:1991;155-191.
35. 2 -adrenoceptor antagonist. Eur. J. Pharmacol. 151:1988;35-42.
36. Shenker A. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: Focus on catecholamine receptor pharmacology. Barness L. A. Advances in pediatrics. vol. 39:1992;337-382 Mosby-Year Book, Inc, St. Louis, MO.
37. 2 -antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol. Biochem. Behav. 45:1993;123-129.
38. Sirviö J., Mazurkiewicz M., Haapalinna A., Riekkinen P. Jr., Lahtinen H., Riekkinen P. J. The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain. Res. Bull. 35:1994;451-455.
39. Steriade M., McCormick D. A., Sejnowski T. J. Thalamo-cortical oscillations in the sleeping and aroused brain. Science. 262:1993;679-685.
40. Vanderwolf C. H., Baker G. B. Evidence that serotonin mediates noncholinergic neocortical low voltage fast activity, noncholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Res. 374:1986;342-356.
41. 2 -adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 297:1989;190-204.
42. Voeller, K. S. Attention deficit disorders: Pathophysiology and treatment. In Mesulam, M. M., ed. Behavioral neurology: Consciousness and attention. American Academy of Neurology, Annual meeting, May 1-7, Washington, DC; 1994:35-48.